The Next Stage of Buprenorphine Care for Opioid Use Disorder.
Ann Intern Med
; 169(9): 628-635, 2018 11 06.
Article
en En
| MEDLINE
| ID: mdl-30357262
ABSTRACT
Buprenorphine has been used internationally for the treatment of opioid use disorder (OUD) since the 1990s and has been available in the United States for more than a decade. Initial practice recommendations were intentionally conservative, were based on expert opinion, and were influenced by methadone regulations. Since 2003, the American crisis of OUD has dramatically worsened, and much related empirical research has been undertaken. The findings in several important areas conflict with initial clinical practice that is still prevalent. This article reviews research findings in the following 7 areas location of buprenorphine induction, combining buprenorphine with a benzodiazepine, relapse during buprenorphine treatment, requirements for counseling, uses of drug testing, use of other substances during buprenorphine treatment, and duration of buprenorphine treatment. For each area, evidence for needed updates and modifications in practice is provided. These modifications will facilitate more successful, evidence-based treatment and care for patients with OUD.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Buprenorfina
/
Medicina Basada en la Evidencia
/
Tratamiento de Sustitución de Opiáceos
/
Antagonistas de Narcóticos
/
Trastornos Relacionados con Opioides
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Año:
2018
Tipo del documento:
Article